Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDR-001 in Overweight or Obesity
NCT06606483Phase 2Not yet recruiting
- Sponsor
- MindRank
- Start
- Sep 2024
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MDR-001 in obesity, Overweight, sponsored by MindRank. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
MDR-001
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT06606483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06606483.